Works matching IS 19466234 AND DT 2022 AND VI 14 AND IP 643

Results: 6
    1
    2

    Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice.

    Published in:
    Science Translational Medicine, 2022, v. 14, n. 643, p. 1, doi. 10.1126/scitranslmed.abm3410
    By:
    • Schäfer, Alexandra;
    • Martinez, David R.;
    • Won, John J.;
    • Meganck, Rita M.;
    • Moreira, Fernando R.;
    • Brown, Ariane J.;
    • Gully, Kendra L.;
    • Zweigart, Mark R.;
    • Conrad, William S.;
    • May, Samantha R.;
    • Dong, Stephanie;
    • Kalla, Rao;
    • Chun, Kwon;
    • Du Pont, Venice;
    • Babusis, Darius;
    • Tang, Jennifer;
    • Murakami, Eisuke;
    • Subramanian, Raju;
    • Barrett, Kimberly T.;
    • Bleier, Blake J.
    Publication type:
    Article
    3
    4
    5

    The small-molecule SMARt751 reverses Mycobacterium tuberculosis resistance to ethionamide in acute and chronic mouse models of tuberculosis.

    Published in:
    Science Translational Medicine, 2022, v. 14, n. 643, p. 1, doi. 10.1126/scitranslmed.aaz6280
    By:
    • Flipo, Marion;
    • Frita, Rosangela;
    • Bourotte, Marilyne;
    • Martínez-Martínez, María S.;
    • Boesche, Markus;
    • Boyle, Gary W.;
    • Derimanov, Geo;
    • Drewes, Gerard;
    • Gamallo, Pablo;
    • Ghidelli-Disse, Sonja;
    • Gresham, Stephanie;
    • Jiménez, Elena;
    • de Mercado, Jaime;
    • Pérez-Herrán, Esther;
    • Porras-De Francisco, Esther;
    • Rullas, Joaquín;
    • Casado, Patricia;
    • Leroux, Florence;
    • Piveteau, Catherine;
    • Kiass, Mehdi
    Publication type:
    Article
    6